MolMed now part of AGC Biologics | LinkedIn
MOLMED S.P.A.: azionisti, dirigenti e profilo società | MLM | IT0001080248 | MarketScreener
Will MolMed soon have its first Cell therapy on the Market?
MolMed now part of AGC Biologics | Iterate.ai
Piazza Affari: Molmed scende verso 0,4305 Euro
Overview of the Italian Primary Markets
1 - [Note: this notice is the English translation of the official version of the 102 notice which will be in Italian language]
Molmed, AGC accetta i paletti del Governo e titolo torna al prezzo Opa - Il Sole 24 ORE
IPO e altre ammissioni - 2008 - Borsa Italiana
OPA su Molmed, i giapponesi la vogliono. I dettagli dell'operazione che fa volare il titolo
Molmed verso delisting. Successo dell'OPA promossa da AGC
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHER
MolMed to test the health of the European sector | Evaluate
MolMed - YouTube
MolMed - YouTube
Indici di Borsa in tempo reale: quotazioni e titoli - Borsa Italiana
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHER
MOLMED S.P.A.: MLM Azione Prezzo| IT0001080248 | MarketScreener
MolMed 06
MOLMED S.P.A. : MLM Stock Price | IT0001080248 | MarketScreener
Will MolMed soon have its first Cell therapy on the Market?
